2017 was an exciting year for the tech sector, especially the FAANG stocks. Lindsey Bell, Investment Strategist for CFRA, and Ryan Vlastelica, Reporter at MarketWatch, join The Long and The Short to discuss the year's ups and downs.
Bell believes Facebook and Netflix had the best year out of all the FAANG stocks. She predicts that because our lives are becoming more and more connected, Facebook, Apple, Amazon, Netflix, and Google will continue to outperform in the coming year. However, Vlastelica says investors should be wary of FAANG stocks going into 2018. Since they are such huge tech companies they are more vulnerable to a market crash.
Plus, how Tesla, Square, and Nvidia made a comeback after the fall tech sell-off. Vlastelica says Square is on an upswing because it's now offering options to pay in Bitcoin, which is a hot, trending cryptocurrency. As far as Tesla, CFRA has a "sell" rating on it, citing that it's overvalued amid increasing competition.
On this edition of Stretching Your Dollar, Bobbi Rebell, author of "Launching Financial Grownups: Live Your Richest Life by Helping Your (Almost) Adult Kids Become Everyday Money Smart," gives some tips on how to save a little extra each week.
Ed Egilinsky, managing director, head of sales and distribution and alternatives at Direxion, offers some advice to investors on how to position their portfolio for retail earnings.
Elon Musk on Tuesday dismissed speculation that he might step down as Tesla's CEO and told the company’s annual shareholders meeting that the electric car and solar panel company would start doing some advertising.
Disney on Tuesday asked a state judge to dismiss a lawsuit filed by a governing board appointed by Gov. Ron DeSantis to oversee Disney World, claiming the company has been the victim of the “weaponizing” powers of government aimed at punishing it for opposing a law dubbed “Don't Say Gay” by critics.
Disgraced Theranos CEO Elizabeth Holmes appears to be soon bound for prison after an appeals court Tuesday rejected her bid to remain free while she tries to overturn her conviction in a blood-testing hoax that brought her fleeting fame and fortune.